Contact Us     Privacy Policy     Terms of Use                                                                                 © Copyright Pharma CI Conference & Exhibition 2008.  All Rights Reserved.
September 15-17, 2008
DAY 3 (Wednesday, September 17, 2008)
Post Conference Workshops (Separate Registration Required)
7:30 - 8:00
Registration and Networking Breakfast
8:00 – 12:00
The Wargame Workshop
Led by Deallus

This workshop is for CI professionals who want to learn more about when and why to run a Wargame as well as
how to execute a successful Wargame.  Wargame is a business tool used to improve decision making through role
play and rigorous analysis of the competitive landscape and your own organization’s capabilities and intentions.  
Decisions are always made under uncertainty and are therefore based upon assumptions.  The participants will
leave with a deeper understanding what is required from a Wargame to ensure your organization reap the most
important benefits of a Wargame; identifying, challenging and improving its assumptions about itself, the
competitors, the market and the future.

  • Registration
  • Introduction to Wargaming
  • Designing a Wargame
  • Break
  • Analytical frameworks in Wargaming
  • Q&A
12:00 - 1:00
Networking Lunch
1:00 – 5:00
A Workshop to Plan for Loss of Exclusivity Due to Patent Loss
Led by Lifescience Dynamics

  • Introductions & Objectives of the workshop
  • Objectives of delegates
  • The role of Lifecycle management and mature product team
  • Introduction to patent loss and generic invasion - Examples
  • Planning for patent loss driven by years to LOE
  • Patent loss defense strategies - full options review and target most promising - leave no stone unturned
  • Risk assessment
  • Intensity of barrier to implement
  • Required investment
  • Viability – Range of potential loss, range of potential returns
  • Most likely ROI
  • Task force team to drive the analysis and implement strategies and tactics
  • Q&A open forum
Introducing a Special Track For Medical Devices:

The field of Competitive Intelligence for Medical Device Professionals continues to grow at an unprecedented rate.  
We have gathered some of the leading experts in this field to offer you some insight on the latest and most
compelling issues facing your industry.  View the agenda below and discover the highlighted program and
networking opportunities available to you, all in one forum.
1:30 – 2:15
Information Superiority Using Mashup Technology Software
Richard Walker
Vice President
Denodo Technologies
2:15 – 3:00
Competitive Intelligence at Medical Conventions: In-Sourcing
Eileen Kelly
Director, Business & Decision Analysis           
OSI Pharmaceutical
3:00 – 3:30
The Case for Offshore Information Analysis in a Changing Industry - a Prudent Strategy for Maximizing
the Return on CI
Rajesh Nair
CEO
Indegene
3:30 – 4:30
Networking & Refreshments in Exhibition Hall
4:30 – 5:30
Challenges in Doing Competitive Intelligence and Market Research in the Medical Device Industry
Included in that discussion will be the difficulties in obtaining pipeline information, having limited access to medical
device product information, shorter product development cycles compared to Pharma (which results in more
competition coming onboard faster)
Sam Rosenbaum
Manager, Market Research
Philips Medical Systems

David Van Mook
Manager, CI
Roche Diagnostics
5:30 – 8:30
Evening Socializing Events! Speed Dating for Business Development, Casino Gaming, Reception &
Networking
DAY 2 (Tuesday, September 16, 2008)
7:15 – 8:15
Registration & Networking Breakfast in Exhibition Hall
8:15 - 8:30
Chairpersons’ Opening Remarks
8:30 – 9:00
Delivering the Therapeutic: Anatomy of a Drug – Device Partnership
Case study of a medical device manufacturer with a pharmaceutical company to design, develop, and test a delivery device for a novel
therapeutic delivered intra-cranially.
Arun Ranchod
Business Development Manager
MEDRAD Corporate Innovations
9:00 - 9:30
Connecting Competitive Intelligence, Customer Needs, Technology Innovation, and R&D Investment
using Technology Roadmapping at Boston Scientific.
This tool has been successful at focusing Research and Development investments at Boston Scientific Technology roadmapping will
be explained as the mapping of the elements of:
  • Competitive threats
  • Customer needs
  • Technology innovation
  • Research & development investments
Richard Traxler
Senior Manager of Technology Planning
Boston Scientific Corporation
9:30 – 10:00
The Challenge of Getting it Right:  Innovation of Medical Device Products in Global Markets
James Down
Vice President and Process Executive / Product Lifecycle Management
BD Diagnostics - Preanalytical Systems
10:00 – 11:00
Networking & Refreshments in Exhibition Hall
11:00 – 11:30
Utilizing Business Intelligence in Support of M&A
Virtually all multi-billion dollar mergers and acquisitions demand regulatory approval; however, all successful transactions regardless
of size and scope require a minimum level of strategic analysis. We will discuss how to design, implement and generate essential
business intelligence processes and tools to perform a world-class M&A assessment. Tools such as product portfolio analysis,
internal networking, financial analysis and more will infuse process and discipline into determining the strategic fit between two
business entities.
Jeffrey Beeny
Corporate Development – Business Intelligence
Thermo Fisher Scientific
11:30 - 12:00
Competitive Aspects of Due Diligence for International M&A and Business Alliances
The presentation will provide an overview of the international due diligence process, focusing in particular on the role of competitive
analysis. Issues discussed will include the analysis of competitor financials, evaluation of synergies, market analysis, opportunity
assessment, and intellectual property issues.
David Van Mook
Manager, CI
Roche Diagnostics
12:00 - 12:30
TBA
Peter Hegi (invited)
Director of Marketing, Programming and System Integration
ANS
a St. Jude Medical Company
12:30  – 1:30
Networking Luncheon Keynote Presentation:
Discovery Without Borders – or Boundaries
From exploring Third World diseases to investigating emerging therapeutic trends, the search for relevant information today presents
new challenges – and opportunities.  This presentation will show how to unleash the power of a global network of information and
uncover original intelligence that’s often buried in secondary and tertiary sources – or even within your own enterprise.  
John Mahoney
Co-Founder and CTO
InfoNgen
1:30 - 2:15
Stories From the Trenches... A Practitioner's View...
Martha Matteo
Former President, SCIP, and Former Director,
Knowledge Management & R&D Planning,
Boehringer Ingelheim
2:15 - 3:15
Bringing Strategic Competitive Insights into New Product Planning & Business Development
  Moderator:
Chandra Ramanathan    
Director, Global Business and Competitive Intelligence  
Bristol-Myers Squibb

Panelists:
Debbie Allison
Senior Director, Global Competitive Intelligence
Merck

Christian Hein
Business Intelligence / Market Research Manager
Actelion Pharmaceuticals Ltd  

Eileen Kelly        
Director, Business & Decision Analysis        
OSI Pharmaceuticals

Craig McHenry
Senior Director, Competitor Insights, Customer & Market Insights
Wyeth

Sam Rosenbaum
Manager, Market Research
Philips Medical Systems
3:15 - 3:45
Networking & Refreshments in Exhibition Hall
3:45 - 4:45
Open Session: Bring your Day-to-Day Problems for us to Solve!  
Monika Giese
Head Global CI
Novartis Pharma AG

Daniel Pascheles
Vice President, Global Competitive Intelligence
Merck

Chandra Ramanathan    
Director, Global Business and Competitive Intelligence  
Bristol-Myers Squibb

Sue Ward
Director, Information & Knowledge Management            
Pfizer

Friederike Wirtz-Brugger        
Associate Director, Scientific Competitive Intelligence (SCI)        
Sanofi-Aventis
4:45 - 5:00
Summary & Attendee Q&A with the Chairpersons
Daniel Pascheles
Vice President, Global Competitive Intelligence
Merck

Sue Ward
Director, Information & Knowledge Management            
Pfizer
5:00
Conference Concludes
Jeffrey Beeny
Corporate Development – Business Intelligence
Thermo Fisher Scientific
Rajesh Nair
CEO
Indegene
Marcus Schabacker
Senior Vice President & Chief Scientific Officer
Conva Tec (a Bristol-Myers Squibb Company)
Tom Daulton
Vice President & General Manager
Cardinal Health
Jeanne Penn
Associate Director, CTI
Genzyme
Richard Traxler
Senior Manager of Technology Planning
Boston Scientific Corporation
James Down
Vice President and Process Executive / Product
Lifecycle Management
BD Diagnostics - Preanalytical Systems
Arun Ranchod
Business Development Manager
MEDRAD Corporate Innovations
David Van Mook
Manager, CI
Roche Diagnostics
Peter Hegi (invited)
Director of Marketing, Programming and System
Integration
ANS
a St. Jude Medical Company
Sam Rosenbaum
Manager, Market Research
Philips Medical Systems
Joseph DeVivo
Global President, Reconstructive Orthopaedics
Smith & Nephew
Featured Speaking Faculty:
Featured Program Agenda:
Woodbridge Hotel & Conference Center
Iselin, New Jersey
DAY 1 (Monday, September 15, 2008)
General Session
7:15 – 8:15
Registration & Networking Breakfast in Exhibition Hall
8:15 - 8:30
Chairpersons’ Opening Remarks
Daniel Pascheles
Vice President, Global Competitive Intelligence
Merck

Sue Ward
Director, Information and Knowledge Management
Pfizer
8:30 - 9:15
Keynote Presentation: “New Realities for Drug/Device Development and Commercialization”
Wayne Rosenkrans
Distinguished Fellow, MIT Center for Biomedical Innovation
Chairman & President, Personalized Medicine Coalition
Chief Applications Officer, SciTech Strategies
9:15 - 10:00
Keynote Presentation
Joseph DeVivo
Global President, Reconstructive Orthopaedics
Smith & Nephew
10:00 - 11:00
Networking & Refreshments in Exhibition Hall
11:00 – 12:00
“How Does This Change What We Do” Keynote Panel  
  Cliff Kalb
President
C.Kalb & Associates, LLC

Tom Daulton
Vice President & General Manager
Cardinal Health

Craig McHenry  
Senior Director, Competitor Insights       
Wyeth

Daniel Pascheles
Vice President, Global Competitive Intelligence
Merck
Renee Pierson
Director of Global Business Intelligence    
Johnson & Johnson Pharmaceutical Services

Chandra Ramanathan    
Director, Global Business and Competitive
Intelligence  
Bristol-Myers Squibb

Sue Ward
Director, Information & Knowledge Management
Pfizer
 
12:00 – 12:30
WalMart and You: From Diagnostics to Distribution Are You Doing Enough to Position Your Company
For 2010?
Steve Levy
Managing Director
Fletcher/CSI, LLC
12:30 – 1:30
Networking Luncheon Keynote Presentation:   
Seeing Patterns That Produce Billion Dollar Insights: CI All-Stars Have Learned how to Turn Oceans ofData
Into Breakthrough Insights.  This presentation will share field research findings and case examples of how winning
CI organizations build systems that enable them to convert data into insights and intelligence that inform leadership
decision-making.
Chris Bogan
CEO
Best Practices